New Zealand markets close in 4 hours 14 minutes

Charles River Laboratories International, Inc. (CRL)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
246.91-3.44 (-1.37%)
At close: 04:00PM EST
246.91 -0.18 (-0.07%)
After hours: 04:07PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 13.22B
Enterprise value 16.38B
Trailing P/E 29.20
Forward P/E 21.46
PEG ratio (5-yr expected) 1.47
Price/sales (ttm)3.37
Price/book (mrq)4.81
Enterprise value/revenue 4.33
Enterprise value/EBITDA 18.80

Trading information

Stock price history

Beta (5Y monthly) 1.32
52-week change 3-25.22%
S&P500 52-week change 3-7.75%
52-week high 3349.84
52-week low 3181.36
50-day moving average 3228.68
200-day moving average 3223.62

Share statistics

Avg vol (3-month) 3589.59k
Avg vol (10-day) 3466.19k
Shares outstanding 550.88M
Implied shares outstanding 6N/A
Float 850.3M
% held by insiders 11.04%
% held by institutions 1101.56%
Shares short (12 Jan 2023) 41.02M
Short ratio (12 Jan 2023) 41.79
Short % of float (12 Jan 2023) 42.60%
Short % of shares outstanding (12 Jan 2023) 42.01%
Shares short (prior month 14 Dec 2022) 41.04M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 24 Dec 2021
Most-recent quarter (mrq)23 Sept 2022


Profit margin 11.54%
Operating margin (ttm)18.23%

Management effectiveness

Return on assets (ttm)5.97%
Return on equity (ttm)17.26%

Income statement

Revenue (ttm)3.78B
Revenue per share (ttm)74.58
Quarterly revenue growth (yoy)10.40%
Gross profit (ttm)1.34B
EBITDA 982.91M
Net income avi to common (ttm)436.39M
Diluted EPS (ttm)8.67
Quarterly earnings growth (yoy)-6.70%

Balance sheet

Total cash (mrq)194.65M
Total cash per share (mrq)3.83
Total debt (mrq)3.35B
Total debt/equity (mrq)125.47
Current ratio (mrq)1.40
Book value per share (mrq)51.63

Cash flow statement

Operating cash flow (ttm)614.14M
Levered free cash flow (ttm)400.65M